The FDA has approved an oral tablet formulation of sodium sulfate, magnesium sulfate, and potassium chloride (Sutab – Braintree) for colon cleansing prior to colonoscopy in adults. A sodium sulfate-based oral solution (Suprep) has been available in the US since 2010. Sutab is the second tablet formulation to be approved for bowel cleansing prior to colonoscopy; a sodium phosphate-based tablet (OsmoPrep) was approved earlier.

COLONOSCOPY PREPARATIONS — Traditional polyethylene glycol (PEG) plus electrolytes solutions for bowel cleansing prior to colonoscopy are isotonic and require patients to ingest up to 4 L of fluid to produce a cathartic effect....  Continue reading

More from Issue 1619
Previous Issue: 1618      February 22, 2021
Coming Soon
Low-Dose Colchicine for Coronary Artery Disease
Drugs for Multiple Sclerosis
Semaglutide (Ozempic) for Weight Loss
In Brief: Hypertension with Erenumab (Aimovig)
Follow us   Twitter LinkedIn YouTube Blog RSS   Email Alerts
Advance Release

The FDA has issued an Emergency Use Authorization (EUA) for Lilly's investigational monoclonal antibodies bamlanivimab (LY-CoV555) and etesevimab (LY-CoV016) to be administered together by IV infusion for treatment of mild to moderate COVID-19 in adults and pediatric patients (aged ≥12 years and weighing ≥40 kg) who are at high risk of progressing to severe disease and/or hospitalization ... Continue reading